Armata (ARMP) Stock Surges 150% After Breakthrough Bacteriophage Trial Results
Armata’s stock performance this week has been nothing short of dramatic. Prior to Oct. 22, ARMP had been trading in the low-$3 range. Once the late-breaking IDWeek data was announced, the shares rocketed – briefly hitting an intraday high near $16 before settling at about $8.87finviz.cominvesting.com. For context, that $8.87 close is the stock’s highest level in years. By midday on Oct. 22, Investing.com already noted the stock was up ~95% on the dayinvesting.com. By market close, FinViz data confirmed a +155.76% one-day gainfinviz.com.